Promising MERS coronavirus vaccine trial in humans

Scientists at the University Medical Center Hamburg-Eppendorf (UKE) and the German Center for Infection Research (DZIF) have now conducted a first-in-human trial with a vaccine against MERS (Middle East Respiratory Syndrome). The MVA-MERS-S vaccine was tolerated well and triggered the development of antibodies and T cell immunity.